Table 1.
Year | Total isolates (no.) | MIC distribution1 |
|||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Ceftiofur (μg/mL) |
Cephalothin (μg/mL) |
||||||||||
≤0.5 | 1 | 2 | 4 | >4 | ≤2 | 4 | 8 | 16 | >16 | ||
2008 | 58 | 53 (91.4) | 4 (6.9) | — | — | 1 (1.7) | 44 (75.9) | — | 5 (8.6) | — | 9 (15.5) |
2009 | 50 | 41 (82.0) | 8 (16.0) | — | — | 1 (2.0) | 39 (78.0) | 5 (10.0) | 1 (2.0) | 1 (2.0) | 4 (8.0) |
2010 | 51 | 45 (88.2) | 6 (11.8) | — | — | — | 38 (74.5) | 7 (13.7) | 5 (9.8) | — | 1 (2.0) |
2011 | 31 | 24 (77.4) | 4 (12.9) | 1 (3.2) | — | 2 (6.5) | 18 (58.1) | 9 (29.0) | 1 (3.2) | — | 3 (9.7) |
2012 | 35 | 27 (77.1) | 5 (14.3) | — | 2 (5.7) | 1 (2.9) | 25 (71.4) | 1 (2.9) | 4 (11.4) | — | 5 (14.3) |
2013 | 43 | 30 (69.8) | 6 (14.0) | 2 (4.7) | 1 (2.3) | 4 (9.3) | 23 (53.5) | 3 (7.0) | 1 (2.3) | 2 (4.7) | 14 (32.6) |
2014 | 42 | 34 (81.0) | 5 (11.9) | — | 2 (4.8) | 1 (2.4) | 29 (69.0) | 4 (9.5) | 4 (9.5) | — | 5 (11.9) |
2015 | 38 | 27 (71.1) | 8 (21.1) | — | — | 3 (7.9) | 25 (65.8) | 7 (18.4) | 1 (2.6) | 1 (2.6) | 4 (10.5) |
2016 | 29 | 18 (62.1) | 10 (34.5) | — | — | 1 (3.4) | 21 (72.4) | 2 (6.9) | 4 (13.8) | 1 (3.4) | 1 (3.4) |
2017 | 76 | 44 (57.9) | 14 (18.4) | 1 (1.3) | — | 17 (22.4) | 44 (57.9) | 11 (14.5) | 3 (3.9) | — | 18 (23.7) |
2018 | 17 | 13 (76.5) | 3 (17.6) | 1 (5.9) | — | — | 11 (64.7) | 5 (29.4) | — | — | 1 (5.9) |
2019 | 13 | 12 (92.3) | 1 (7.7) | 7 (53.8) | 5 (38.5) | — | — | 1 (7.71) |
The MIC breakpoints for ceftiofur were based on Clinical and Laboratory Standards Institute guidelines (CLSI, 2018b). Klebsiella isolates were considered resistant to ceftiofur or cephalothin when the MIC exceeded 4.0 μg/mL.